NCT04205708

Brief Summary

Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
183

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 14, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 19, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 24, 2021

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

December 6, 2023

Status Verified

December 1, 2023

Enrollment Period

2.1 years

First QC Date

November 19, 2019

Last Update Submit

December 4, 2023

Conditions

Keywords

silicapublic healthearly preventionsilicosisscreeningOklahomalung diseasepulmonologyPneumoconiosislungdust exposureoccupational healthcommunity health

Outcome Measures

Primary Outcomes (3)

  • Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)

    Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)

    Single point assessment at baseline survey

  • Percentage of participants who report any exposure to silica

    Percentage of participants who report any exposure to silica

    Single point assessment at baseline survey

  • Prevalence of silicosis among study group

    Percentage of participants with confirmed diagnosis of silicosis

    Single point assessment at clinic visit

Secondary Outcomes (1)

  • Analysis to determine if any demographic, work history, or other trait correlates with increased silica exposure

    Single point assessment at baseline survey

Interventions

Tuberculosis testDIAGNOSTIC_TEST

Tuberculosis (TB) test: A blood sample is collected for lab testing to determine if you have tuberculosis (QuantiFeron test). Alternatively, the test is done by injecting a small amount of fluid (called tuberculin) into the skin on the lower part of the arm. A person given the tuberculin skin test must return within 48 to 72 hours to have a trained health care worker look for a reaction on the arm.

Also known as: Mantoux skin test, QuantiFeron test
Chest X-rayDIAGNOSTIC_TEST

Chest X ray: non-invasive medical test that helps physicians diagnose and treat medical conditions of the lungs and chest. The Chest X-ray will be done to check for abnormalities on the lungs. The test is non-invasive.

A pulmonary function test (PFT, spirometry) is a breathing test that measures how much air your lungs can hold as well as how hard and fast you can blow air out of your lungs. The test is not invasive and involves blowing into a machine.

Also known as: Spirometry, Forced Spirometry

Eligibility Criteria

Age30 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMen Male gender identity
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care clinic, community sample Participants will be recruited from waiting rooms or other common spaces at participating community health clinics.

You may qualify if:

  • Male 30 years or older
  • Past or present employment in dusty environment, exposed to dust at work
  • Ability to consent and answer the questionnaire

You may not qualify if:

  • Female
  • Never exposed to dusty environment or never exposed to dust at work
  • Inability to consent and answer the questionnaire
  • Age 29 years or younger

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104, United States

Location

MeSH Terms

Conditions

SilicosisLung DiseasesPneumoconiosis

Interventions

Diagnostic ImagingRespiratory Function TestsSpirometry

Condition Hierarchy (Ancestors)

Lung Diseases, InterstitialRespiratory Tract DiseasesLung InjuryOccupational Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Respiratory System

Study Officials

  • Jad Kebbe, MD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2019

First Posted

December 19, 2019

Study Start

January 14, 2019

Primary Completion

February 24, 2021

Study Completion

June 10, 2022

Last Updated

December 6, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

Researchers may request a deidentified dataset. The de-identified dataset may be shared between other investigators of the same institution as the PI, in accordance with University and Institutional Review Board policies. Any investigator not affiliated with the University of Oklahoma Health Sciences Center who desires access to a de-identified dataset may do so by coordinating a Data Use Agreement between the investigator's institution and the PI's institution. Datasets will only be released with an active Data Use Agreement or other similar agreement with the University of Oklahoma Health Sciences Center.

Time Frame
2 years after publication
Access Criteria
Active Data Use Agreement or other similar agreement with the University of Oklahoma Health Sciences Center

Locations